SYNGENEHealthcare Research, Analytics & Technology
Syngene International Ltd — Cash Flow Statement
₹389.90
-1.04%
Syngene International Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Interest Paid Cff | -13.80 Cr | -28.80 Cr | -34.50 Cr | -17.50 Cr | — |
| Cash Dividends Paid | -50.30 Cr | -50.30 Cr | -40.10 Cr | — | — |
| Common Stock Dividend Paid | -50.30 Cr | -50.30 Cr | -40.10 Cr | 0.00 | — |
| Net Common Stock Issuance | 0.50 Cr | 0.60 Cr | — | 0.00 | 0.80 Cr |
| Common Stock Issuance | 0.50 Cr | 0.60 Cr | — | 0.00 | 0.80 Cr |
| Net Issuance Payments Of Debt | -24.60 Cr | -436.20 Cr | -258.10 Cr | -5.80 Cr | — |
| Net Short Term Debt Issuance | 17.10 Cr | -45.80 Cr | -258.10 Cr | -5.80 Cr | — |
| Net Long Term Debt Issuance | -41.70 Cr | -390.40 Cr | 0.00 | 0.00 | — |
| Long Term Debt Payments | -41.70 Cr | -390.40 Cr | — | 0.00 | -381.10 Cr |
| Investing Cash Flow | -744.70 Cr | -495.60 Cr | -656.40 Cr | -611.50 Cr | — |
| Interest Received Cfi | 50.30 Cr | 81.50 Cr | 54.00 Cr | 26.30 Cr | — |
| Net Investment Purchase And Sale | -24.90 Cr | 464.80 Cr | -173.90 Cr | -162.30 Cr | — |
| Sale Of Investment | 3.53K Cr | 4.52K Cr | 2.59K Cr | 4.30K Cr | — |
| Purchase Of Investment | -3.55K Cr | -4.05K Cr | -2.77K Cr | -4.47K Cr | — |
| Net Business Purchase And Sale | 0.00 | -553.20 Cr | -18.20 Cr | 0.00 | — |
| Purchase Of Business | 0.00 | -553.20 Cr | -18.20 Cr | 0.00 | — |
| Net Intangibles Purchase And Sale | -9.80 Cr | -18.80 Cr | -11.70 Cr | -0.20 Cr | — |
| Purchase Of Intangibles | -9.80 Cr | -18.80 Cr | -11.70 Cr | -0.20 Cr | — |
| Net PPE Purchase And Sale | -760.30 Cr | -469.90 Cr | -506.60 Cr | -475.30 Cr | — |
| Sale Of PPE | 0.00 | 22.10 Cr | 0.00 | — | — |
| Purchase Of PPE | -760.30 Cr | -492.00 Cr | -506.60 Cr | -475.30 Cr | — |
| Operating Cash Flow | 1.17K Cr | 1.04K Cr | 823.50 Cr | 580.60 Cr | — |
| Taxes Refund Paid | -115.20 Cr | -125.10 Cr | -136.80 Cr | -105.80 Cr | — |
| Change In Working Capital | 152.10 Cr | 156.00 Cr | -18.20 Cr | -179.70 Cr | — |
| Change In Other Current Assets | -12.60 Cr | 82.60 Cr | -73.90 Cr | -78.30 Cr | — |
| Change In Payable | 184.30 Cr | -102.60 Cr | 202.20 Cr | 54.60 Cr | — |
| Change In Inventory | 74.30 Cr | 89.30 Cr | -153.40 Cr | -119.80 Cr | — |
| Change In Receivables | -93.90 Cr | 86.70 Cr | 6.90 Cr | -36.20 Cr | — |
| Other Non Cash Items | -1.30 Cr | -15.20 Cr | -25.90 Cr | 1.70 Cr | — |
| Stock Based Compensation | 37.30 Cr | 0.50 Cr | 23.60 Cr | 37.10 Cr | — |
| Provisionand Write Offof Assets | 13.70 Cr | 9.90 Cr | -1.70 Cr | 4.60 Cr | — |
| Deferred Tax | 158.90 Cr | 95.00 Cr | 129.20 Cr | 88.60 Cr | — |
| Depreciation And Amortization | 432.60 Cr | 425.90 Cr | 366.50 Cr | 309.70 Cr | — |
| Amortization Cash Flow | 8.90 Cr | 7.90 Cr | 5.80 Cr | — | — |
| Depreciation | 423.70 Cr | 418.00 Cr | 360.70 Cr | 309.70 Cr | — |
| Gain Loss On Investment Securities | -13.30 Cr | -11.90 Cr | -3.10 Cr | -4.30 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 3.70 Cr | -3.60 Cr | 24.50 Cr | 22.40 Cr | — |
| Net Income From Continuing Operations | 496.20 Cr | 510.00 Cr | 464.40 Cr | 395.80 Cr | — |
| Free Cash Flow | 397.50 Cr | 531.30 Cr | 305.20 Cr | 105.10 Cr | — |
| Repayment Of Debt | -41.70 Cr | -390.40 Cr | — | 0.00 | -381.10 Cr |
| Issuance Of Capital Stock | 0.50 Cr | 0.60 Cr | — | 0.00 | 0.80 Cr |
| Capital Expenditure | -770.10 Cr | -510.80 Cr | -518.30 Cr | -475.50 Cr | — |
| End Cash Position | 367.10 Cr | 85.70 Cr | 89.50 Cr | 261.80 Cr | — |
| Other Cash Adjustment Outside Changein Cash | -0.10 Cr | 0.10 Cr | — | — | — |
| Beginning Cash Position | 85.70 Cr | 89.50 Cr | 261.80 Cr | 323.30 Cr | — |
| Effect Of Exchange Rate Changes | 0.30 Cr | 1.10 Cr | 3.10 Cr | 0.70 Cr | — |
| Changes In Cash | 281.20 Cr | -4.90 Cr | -175.40 Cr | -62.20 Cr | — |
| Financing Cash Flow | -141.70 Cr | -551.40 Cr | -342.50 Cr | -31.30 Cr | — |
| Net Other Financing Charges | 0.10 Cr | -0.10 Cr | — | — | — |
| Issuance Of Debt | — | — | — | 0.00 | 515.30 Cr |
| Long Term Debt Issuance | — | — | — | 0.00 | 515.30 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Syngene International Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.